search

Standard Biotools Inc (LAB)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
ARCHIMED Life Science Tools & Services Completes Acquisition of Standard BioTools’ Microfluidics Business, Now Biomark Scientific
Nov 3, 2026

ARCHIMED Life Science Tools & Services Completes Acquisition of Standard BioTools’ Microfluidics Business, Now Biomark Scientific

Global private equity healthcare specialist ARCHIMED has completed its acquisition of Standard BioTools' Microfluidics Business, which will now operate independently as Biomark Scientific. Biomark Scientific specializes in high-throughput and multi-assay genomics systems, offering versatile and scalable genomic profiling through its Biomark™ platform, including the automated Biomark X9 system. This acquisition aims to expand Biomark Scientific's capabilities, fortify global growth in clinical research and public health markets, and support scientific discovery.
Company relevance
100.00%
Company sentiment
Somewhat-Bullish
Overall sentiment
Somewhat-Bullish